The effect of admission hyperglycemia in stroke patients treated with thrombolysis.
Summary of "The effect of admission hyperglycemia in stroke patients treated with thrombolysis."
Abstract Background: Acute hyperglycemia has been shown to correlate negatively with outcome in stroke patients yet the mechanism remains controversial. The aim of our study is to study the immediate and long term effects of admission hyperglycemia on outcome in a cohort of stroke patients treated with thrombolytic therapy Methods: We reviewed the prospective dataset of a statewide telestroke network for the characteristics of 195 patients who received intravenous tissue plasminogen activator via telemedicine during a 27-months period. We compared outcome and improvement rate of patients with and without hyperglycemia. We defined good outcome as a modified Rankin Scale score ≤ 2 and neurological improvement after thrombolysis as either a decrease in NIHSS at 24 hours by 5 points from baseline or an NIHSS of 0 at 24 hours Results: Thirty-one percent of patients had admission hyperglycemia (Blood sugar > 144). Patients with admission hyperglycemia (HG) had higher 3 month mortality and poor outcome rates than those without (NG). The improvement rates with thrombolysis however, were similar between the two groups. Conclusions: Admission hyperglycemia is associated with poor neurological recovery in patients with acute stroke despite thrombolytic treatment without having an effect on the clinical response to thrombolytic therapy. Larger studies are needed to confirm this finding.
Affiliation
1Department of Neurology, University of Arkansas for Medical Sciences.
Journal Details
This article was published in the following journal.
Name: The International journal of neuroscience
ISSN: 1563-5279
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22720729
- DOI: http://dx.doi.org/10.3109/00207454.2012.702820
Medical and Biotech [MESH] Definitions
Heat Stress Disorders
A group of conditions due to overexposure to or overexertion in excess environmental temperature. It includes heat cramps, which are non-emergent and treated by salt replacement; HEAT EXHAUSTION, which is more serious, treated with fluid and salt replacement; and HEAT STROKE, a condition most commonly affecting extremes of age, especially the elderly, accompanied by convulsions, delusions, or coma and treated with cooling the body and replacement of fluids and salts. (From Segen, Dictionary of Modern Medicine, 1992)
Patient Admission
The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution.
School Admission Criteria
Requirements for the selection of students for admission to academic institutions.
Intracranial Arteriovenous Malformations
Congenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.
Angiotensin Ii
An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.
PubMed Articles
Post-Thrombolytic Hyperglycemia and 3-Month Outcome in Acute Ischemic Stroke.
Background: Treating hyperglycemia in acute ischemic stroke may be beneficial, but knowledge on its prognostic value and optimal target glucose levels is scarce. We investigated the dynamics of glucos...
Subacute Seizure Incidence in Thrombolysis-treated Ischemic Stroke Patients.
BACKGROUND: To assess the incidence of seizures in acute ischemic stroke patients treated with chemical (tPA) thrombolysis. METHODS:...
Ischemic stroke patients following intravenous thrombolysis : Outcome in a regional stroke center.
BACKGROUND: We wanted to compare the outcome following IV thrombolysis in our patients with ischemic stroke with the outcome reported from the phase 3 registration trials and oth...
BACKGROUND: In September, 2008, the European Acute Stroke Study III (ECASS III) randomised trial and the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry (SITS-IST...
De-novo thrombolysis for recurrent stroke in a patient with prior history of thrombolysis.
A 67-year-old male with prior history of atrial fibrillation was admitted to our center with acute onset of aphasia. He was treated by intravenous thrombolysis. Approximately 2 years later he presente...
Clinical Trials
Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry
The clinical and radiological data of patients with an acute ischemic stroke treated with intravenous thrombolysis (IVT) or intraarterial thrombolysis (IAT) in a Swiss stroke unit are asse...
The Intravascular Cooling in the Treatment of Stroke 2/3 (ICTuS 2/3) Trial
The purpose of this trial is to determine whether the combination of thrombolysis and hypothermia is superior to thrombolysis alone for the treatment of acute ischemic stroke.
The Effect of Insulin on Infarct Size and Neurologic Outcome After Acute Stroke
Between twenty and fifty percent of people who have acute stroke have hyperglycemia (high blood sugar) with it. Research has shown an association between hyperglycemia and poor recovery f...
"Mobile Stroke-Unit" for Reduction of the Response Time in Ischemic Stroke
Stroke, the most common cause of permanent disability, the second most common cause of dementia and third most common cause of death, has tremendous socio-economic consequences. Currently...
Reperfusion Therapy in Acute Ischemic Stroke With Unclear Onset
This study will test the hypothesis whether patients with unclear-onset stroke (UnCLOS) treated with thrombolysis could achieve a prespecified rate of good clinical outcome. The secondary...
